ArticleJournal of clinical and experimental dentistry2025
Myofunctional Responses in Obstructive Sleep Apnea Syndrome in Children Following the Use of Two Oral Orthopedic Devices.
Article in Journal of clinical and experimental dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Controlled Prospective Evidence of Rapid Maxillary Expansion Efficacy in Pediatric Obstructive Sleep Apnea: A Systematic Review Update.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rapid maxillary expansion (RME) is less invasive and an efficient method of treatment for obstructive sleep apnea syndrome (OSAS). Objective: To assess the therapeutic impact of oral orthopedic appliances in the treatment of obstructive sleep apnea syndrome with polysomnography (PSG), electromyography (EMG), bite force measurement (BFM), questionnaires, and cephalometric analysis. Material and Methods: Eleven children (aged seven to eleven years) underwent three months of treatment with the Hyrax device, followed by the installation of the Balter´s Bionator appliance. Quality analysis, type III polysomnography (PSG), electromyography (EMG), and bite force measurement (BFM) were conducted. The analysis were performed through eleven months of treatment. The distributional normality were verified by the Kolmogorov-Smirnov, For these data, the Student test was performed. For data with non-normal distribution, the Wilcoxon test was performed. All analyzes were performed with a significance level of 5%. Results: Polysomnography data showed that severe scores became moderate or mild with the use of the devices. Electromyography, during rest periods, demonstrated that only the right temporal muscle exhibited increased electrical activity, while both muscles showed increased activity during dental clenching. There was an increase in the masseter and right temporalis during grape chewing. Bite Force Measurement (BFM) did not reveal any statistical difference before and after treatment. Questionnaire responses showed a statistically significant difference in the Sleep Disturbance Scale and OSA-18-PV. Conclusions: It can be concluded that the use of the Balters Hyrax and Bionator devices in class II children and children with OSAS is a safe and effective treatment alternative.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.